The concept is straightforward: combine the two most studied healing peptides at an optimal ratio so they work together
Objective inflammation assessment: Depending on the clinical situation, assessment may include blood tests, stool markers such as faecal calprotectin, imaging, colonoscopy, gastroscopy or other investigations to understand whether symptoms are linked to active inflammation or another gut condition
Potential direct benefits suggested by preclinical research include reduction of neuroinflammation, enhancement of neuronal insulin signaling, promotion of synaptic plasticity, and possible reduction in pathological protein accumulation
This indicates that patients may still experience the appetite regulation benefits of GLP-1s, even at lower doses, and the effects may be more gradual and gentler, which could be beneficial for long-term adherence
Units measure the amount drawn into an insulin syringe